Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002496 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
A Phase 3 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00002496 is a Phase 3 study that has completed, run by Radiation Therapy Oncology Group.
The verdict
NCT00002496, a Phase 3 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known if chemotherapy plus radiation therapy is more effective than radiation therapy alone in treating patients with advanced cancer of the larynx. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients with advanced cancer of the larynx.
Interventions
- DRUG cisplatin
- DRUG fluorouracil
- PROCEDURE conventional surgery
- DRUG chemotherapy
- RADIATION low-LET cobalt-60 gamma ray therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1992-08 |
| Est. Completion | 2013-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002496
The ClinicalTrials.gov registry entry for NCT00002496 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00002496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002496 about?
NCT00002496 is a clinical study titled "Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known if chemotherapy plus radiation therapy is more effective than radiation therapy alone in treati...
What is the current status of trial NCT00002496?
This trial is currently completed. It is a Phase 3 study. The study started on 1992-08. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00002496?
The interventions under investigation include: cisplatin (DRUG), fluorouracil (DRUG), conventional surgery (PROCEDURE), chemotherapy (DRUG), low-LET cobalt-60 gamma ray therapy (RADIATION).
Who is sponsoring clinical trial NCT00002496?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.